Earnings calendar/DRUG
Bright Minds Biosciences Inc. (DRUG)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Dec 22, 2026
Consensus estimate row
EPS target
$-1.54
Street estimate
Revenue target
—
Street estimate
Trailing EPS (avg 4Q)
$-0.33
Beat rate last 4: 100%
Latest EPS YoY
+67.9%
vs 2025-08-14
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 17, 2026
EPS beat
EPS actual / est
$-0.17 / $-1.23
+86.2%
Revenue actual / est
— / —
—
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 12/22/2026upcoming | $-1.54 | Pending | — | — | Pending | — |
| 8/17/2026 | $-1.23 | $-0.17 | +86.2% | — | Pending | — |
| 8/14/2026 | $-1.28 | $-0.17 | +86.8% | — | Pending | — |
| 8/13/2026 | $-1.28 | $-0.17 | +86.8% | — | Pending | — |
| 5/20/2026 | $-1.06 | $-0.80 | +24.5% | — | Pending | — |
| 5/19/2026 | $-1.06 | $-0.80 | +24.7% | — | Pending | — |
| 5/18/2026upcoming | $-0.87 | Pending | — | — | Pending | — |
| 5/15/2026upcoming | $-0.87 | Pending | — | — | Pending | — |
| 2/12/2026 | $-0.98 | $-0.70 | +28.6% | — | Pending | — |
| 12/23/2025 | $-0.56 | $-0.41 | +27.1% | — | Pending | — |
| 8/14/2025 | $-0.59 | $-0.53 | +10.2% | — | Pending | — |
| 5/15/2025 | $-0.39 | $-0.29 | +25.6% | — | Pending | — |
| 2/13/2025 | $-0.23 | $0.01 | +104.3% | — | Pending | — |
| 12/30/2024 | $-0.44 | $-0.12 | +72.9% | — | Pending | — |
| 8/14/2024 | — | $0.04 | — | — | Pending | — |
| 5/15/2024 | — | $-0.10 | — | — | Pending | — |
| 2/12/2024 | — | $-0.32 | — | — | Pending | — |
| 12/29/2023 | — | $-0.30 | — | — | Pending | — |
| 8/14/2023 | — | $-0.29 | — | — | Pending | — |
| 5/15/2023 | — | $-0.08 | — | — | Pending | — |
| 2/7/2023 | — | $-0.10 | — | — | Pending | — |
| 12/29/2022 | — | $-0.15 | — | — | Pending | — |
| 8/12/2022 | — | $-0.87 | — | — | Pending | — |
| 5/16/2022 | — | $-1.52 | — | — | Pending | — |
| 2/14/2022 | — | $-1.61 | — | — | Pending | — |
| 12/29/2021 | — | $-1.61 | — | — | Pending | — |
| 7/17/2021 | — | $-1.26 | — | — | Pending | — |
| 6/17/2021 | — | $-0.46 | — | — | Pending | — |
| 3/31/2021 | — | $-0.91 | — | — | Pending | — |
| 9/30/2020 | — | $-0.25 | — | — | Pending | — |
| 6/30/2020 | — | $-0.03 | — | — | Pending | — |
| 3/31/2020 | — | $-0.00 | — | — | Pending | — |
| 12/31/2019 | — | $-0.02 | — | — | Pending | — |
Need DRUG data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.